Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Adult ADHD News

Meta-Analysis Characterizes Neural Activation Differences in ADHD and ASD
News
Meta-Analysis Characterizes Neural Activation Differences in ADHD and ASD
08/05/2024
A meta-analysis of 243 studies found both similar and different neural activations during task completion in participants with ADHD and ASD compared with typically developing control subjects. Researchers published their findings in the...
A meta-analysis of 243 studies found both similar and different neural activations during task completion in participants with ADHD and ASD compared with typically developing control subjects. Researchers published their findings in the...
A meta-analysis of 243 studies...
08/05/2024
Psych Congress Network
Continuing ADHD Treatment During Pregnancy May Help Patients Better Manage OUD
News
Continuing ADHD Treatment During Pregnancy May Help Patients Better Manage OUD
07/31/2024
Pregnant patients with comorbid ADHD and OUD who remain on their ADHD medications throughout pregnancy are more likely to adhere to OUD treatment and less likely to overdose than patients who stop taking ADHD medication, according to results...
Pregnant patients with comorbid ADHD and OUD who remain on their ADHD medications throughout pregnancy are more likely to adhere to OUD treatment and less likely to overdose than patients who stop taking ADHD medication, according to results...
Pregnant patients with comorbid...
07/31/2024
Psych Congress Network
ADHD Diagnosis Occurs Later in Female Patients, Those With Inattentive Symptoms
News
ADHD Diagnosis Occurs Later in Female Patients, Those With Inattentive Symptoms
07/10/2024
Attention-deficit/hyperactivity disorder (ADHD) is diagnosed at older ages in female patients and is more often accompanied by depression and anxiety, according to study findings published in the Journal of Attention Disorders.
Attention-deficit/hyperactivity disorder (ADHD) is diagnosed at older ages in female patients and is more often accompanied by depression and anxiety, according to study findings published in the Journal of Attention Disorders.
Attention-deficit/hyperactivity...
07/10/2024
Psych Congress Network

Advertisement

Video Game Treatment for Adults With ADHD Cleared by FDA
News
Video Game Treatment for Adults With ADHD Cleared by FDA
07/02/2024
AKL-T01 is indicated for adults with primarily inattentive or combined-type ADHD who have a demonstrated attention issue.
AKL-T01 is indicated for adults with primarily inattentive or combined-type ADHD who have a demonstrated attention issue.
AKL-T01 is indicated for adults...
07/02/2024
Psych Congress Network
ADHD Linked With Hiked Risk of Lewy Body Disease
News
ADHD Linked With Hiked Risk of Lewy Body Disease
06/25/2024
Attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of Lewy Body disease (LBD), according to results from a recent prospective observational cohort study published in The American Journal of Geriatric...
Attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of Lewy Body disease (LBD), according to results from a recent prospective observational cohort study published in The American Journal of Geriatric...
Attention-deficit/hyperactivity...
06/25/2024
Psych Congress Network
More ADHD Inattention in Young Adulthood Predicts Midlife Dissatisfaction
News
ADHD Symptoms Stable During Transition into Adulthood With Complex Impacts on Life Success
06/10/2024
Jolynn Tumolo
Symptoms of attention-deficit/hyperactivity disorder (ADHD) are generally stable throughout the transition from emerging adulthood to early mid-adulthood, according to a study published online in the Journal of Attention Disorders.
Symptoms of attention-deficit/hyperactivity disorder (ADHD) are generally stable throughout the transition from emerging adulthood to early mid-adulthood, according to a study published online in the Journal of Attention Disorders.
Symptoms of...
06/10/2024
Psych Congress Network

Advertisement

Stimulant Use May Increase Heart Damage Risk in Young Adults With ADHD
News
Stimulant Use May Increase Heart Damage Risk in Young Adults With ADHD
05/07/2024
Evi Arthur
Stimulant use for attention-deficit/hyperactivity disorder (ADHD) could increase risk of heart damage in young adults, according to recent results published in the Journal of the American College of Cardiology. 
Stimulant use for attention-deficit/hyperactivity disorder (ADHD) could increase risk of heart damage in young adults, according to recent results published in the Journal of the American College of Cardiology. 
Stimulant use for...
05/07/2024
Psych Congress Network
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
News
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
05/01/2024
Evi Arthur
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of...
05/01/2024
Psych Congress Network
ADHD Medication Use May Lower Mortality
News
ADHD Medication Use May Lower Mortality
04/09/2024
Evi Arthur
Medication initiation in patients with attention-deficit/hyperactivity disorder (ADHD) was associated with significantly lower all-cause mortality, according to recent results from an observational nationwide cohort study published in JAMA. 
Medication initiation in patients with attention-deficit/hyperactivity disorder (ADHD) was associated with significantly lower all-cause mortality, according to recent results from an observational nationwide cohort study published in JAMA. 
Medication initiation in...
04/09/2024
Psych Congress Network

Advertisement

Adults With ADHD Report Camouflaging Their Symptoms
News
Adults With ADHD Report 'Camouflaging' Their Symptoms
04/01/2024
Jolynn Tumolo
Adults with ADHD camouflage, or use strategies to minimize the visibility of symptoms, less than adults with autism but more than age and sex-matched peers without either diagnosis, according to study results published in the journal Autism...
Adults with ADHD camouflage, or use strategies to minimize the visibility of symptoms, less than adults with autism but more than age and sex-matched peers without either diagnosis, according to study results published in the journal Autism...
Adults with ADHD camouflage, or...
04/01/2024
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use